ÂÜÀòÂÒÂ×

Christine Zurawski is an experienced Clinical Account Manager currently working at Cycle Pharmaceuticals, focusing on rare diseases related to immunology and neurology in key clinical academic centers across New York City and New Jersey. Prior to this role, Christine excelled at Travere Therapeutics, promoting Cholbam for bile acid synthesis and peroxisomal disorders, and at Alcresta Therapeutics, where Christine was pivotal in launching RELIZORB for fat malabsorption in rare diseases. Christine also held positions at Medi-Globe Corporation, Novartis, and Solvay, achieving significant sales growth and successful product launches. Christine holds a Bachelor of Science degree in Kinesiology and Exercise Science from William Paterson University of New Jersey.